Berlin’s Apheris and Ginkgo bring pharma giants together to train AI on 10,000 antibodies

Ginkgo Datapoints and Berlin-based Apheris today announced that the Antibody Developability Consortium has kicked off with its founding members. The Consortium is a new industry collaboration designed…

Milan-based biotech Aptadir Therapeutics raises $45M seed round

AMilan-based biotech company developing novel treatments for difficult to treat genetic conditions has raised a $45m seed round, it said today.Theseed round investment in Aptadir Therapeutics is one o…

Hoxton Ventures backs human hair toothpaste pioneer in $4M round

HoxtonVentures is backing a UK startup which hopes to commercialise a protein sourcedfrom human hair or sheep’s wool into a toothpaste to protect against toothdecay. TheLondon-based early-stage VC, wh…

PANDA Therapeutics secures €160K to advance multi-target Alzheimer’s therapy

Biotech startup PANDA Therapeutics has obtained €160,000 (CHF 150,000) from Venture Kick to advance a new treatment for Alzheimer’s disease toward clinical development. By targeting multiple harmful p…

The Enhanced Games — tech’s steroid extravaganza — didn’t pay off, as company posts $60 million loss

An effort to transform the world of sports through steroid use doesn’t exactly seem to be bearing financial fruit.

EcoNomad raises £400K to bring waste-to-energy tech to small livestock farms

UK‑based startup EcoNomad Solutions has received £230,000 in funding from the British Design Fund (BDF) to help small livestock farms cut methane emissions, reduce rising energy and fertiliser costs, …

Efferon is ‘selling time’ in the race to treat sepsis

Every minute one person in Europe dies from sepsis or septic shock. Sepsis arises when the body’s response to an infection injures its own tissues and organs. It may lead to shock, multi-organ failure…

German biotech AquaNab secures funding to tackle sea lice with nanoantibodies

Hamburg-basedbiotechnology startup AquaNab has secured investment from Nordic Foodtech VC toadvance its nanoantibody platform for treating and preventing diseases inaquaculture. The investment marks t…

Clean Cells acquires Anaquant to expand biopharma quality control with mass spectrometry expertise

French biopharma quality control services provider Clean Cells today announces its acquisition of French company Anaquant, a specialist in mass-spectrometry-based bioanalysis. Founded in 2020, Clean C…

Qureight secures $20M Series B to expand AI-powered imaging platform for clinical trials

Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has raised $20 mil…